Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02538055
Other study ID # R18HS019239
Secondary ID
Status Completed
Phase N/A
First received July 6, 2015
Last updated April 26, 2016
Start date September 2011
Est. completion date January 2016

Study information

Verified date April 2016
Source Weill Medical College of Cornell University
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

As many as 75% of people with diabetes report chronic pain. While cognitive behavioral therapy (CBT) improves pain and functioning in individuals with chronic pain, many rural and underserved communities lack resources for such programs. The investigators tested the hypothesis that a CBT-based program delivered by community health workers (CHW) can improve quality of life in individuals with diabetes and chronic pain.


Description:

Diabetes mellitus (DM) is a growing chronic disease, affecting 20% of the population of Alabama. However, type 2 DM (90-95% of all DM) rarely occurs in isolation; 25% of all Americans report chronic pain, rising to 58-70% of community-dwellers over age 65. The National Center for Health Statistics reported in 2006 that chronic pain affected 76.2 million Americans, more than cancer, heart disease, stroke and DM combined. Despite the high prevalence of chronic pain, evidence suggests that under treatment is common. In one study, 68% of primary care physicians estimated that chronic pain was inadequately managed in their patients, and 60% thought improving physician education could help. Indeed, 40% of people with moderate to severe pain report not getting adequate relief.

Chronic pain is a significant barrier to successful DM self-care; patients with chronic pain have lower medication adherence and are less likely to exercise. Fully 60-80% of DM patients report chronic pain, and in our ENCOURAGE pilot study (Safford, PI), all but one participant did so. About 20-25% of pain may stem from neuropathy, but at least 1/3 stems from OA (osteoarthritis), and coexistence of multiple causes is common. Over half of patients >65 and 60% of women of any age report OA, demonstrating the very high prevalence of OA in this demographic group. Pain management dominated 20% of primary care visits for diabetic patients in one study, and decreased the likelihood of DM risk factor management. Not surprisingly, depressive symptoms are common in individuals with OA and chronic pain, and are also associated with non adherence to DM self-care behavior. Pain is therefore a barrier to not only quality of life, but to successful DM self-care.

While cognitive behavioral therapy (CBT) improves pain and functioning in individuals with chronic pain, many rural and underserved communities lack resources for such programs. The investigators tested the hypothesis that a CBT-based program delivered by community health workers (CHW) can improve quality of life in individuals with diabetes and chronic pain.


Recruitment information / eligibility

Status Completed
Enrollment 230
Est. completion date January 2016
Est. primary completion date January 2016
Accepts healthy volunteers No
Gender Both
Age group 19 Years and older
Eligibility Inclusion Criteria:

- 19 or older in age

- diagnosed with diabetes

- under the care of a doctor

- experienced chronic pain in the past month

Exclusion Criteria:

- not community dwelling

- less than 19 years old

- pregnant

- end-stage medical conditions with limited life expectancy

- no access to telephone

- does not speak english,

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
Living Healthy
This intervention tested the effects of a community health worker delivered lifestyle modification program based on cognitive behavioral therapy on diabetes and pain outcomes in individuals with diabetes and chronic pain.
General Health Program
Participants in this arm worked with a Community Health Worker (CHW) who provided a general health program that consisted of didactic information of unrelated general health information. Participants received the same number of contacts with their CHW as the intervention arm. Participants and CHW interacted by telephone 8 times over 3 months.

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Weill Medical College of Cornell University Agency for Healthcare Research and Quality (AHRQ)

Outcome

Type Measure Description Time frame Safety issue
Primary Glycated hemoglobin (A1c) fingerstick, point of care a1c test change in A1c in 3 months No
Primary Blood pressure measured using digital automated blood pressure monitor Change in blood pressure measure in 3 months No
Primary Functional status (WOMAC) Assessed using the the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) change in functional status in 3 months No
Primary Quality of Life (SF12) self report using the Short form-12 (SF12) Change in quality of life measures at 3 months No
Secondary Pain (McGill Pain Questionnaire, ICOAP) self report using the following measures: McGill Pain Questionnaire, A measure of intermittent and Constant Osteoarthritis Pain (ICOAP), Change in pain measures at 3 months No
Secondary Body mass index (BMI) weight measured using digital scale, height measured using stadiometer change in BMI in 3 months No
Secondary Diabetes knowledge (Spoken Knowledge in Low Literacy in Diabetes Scale) assessed using a modified version of the Spoken Knowledge in Low Literacy in Diabetes Scale change in diabetes knowledge in 3 months No
Secondary diabetes management self-efficacy (PDSMS) assessed using the Perceived Diabetes Self-Management Scale (PDSMS) change in diabetes management self efficacy measures in 3 months No
Secondary Self efficacy in arthritis pain (Arthritis Self-Efficacy Scale) assessed using the Pain Self Efficacy Subscale of the Arthritis Self-Efficacy Scale change in pain self efficacy measures in 3 months No
Secondary Patient Activation Measure (PAM-13) assessed using the 13 item patient activation measure (PAM-13) change in patient activation measures in 3 months No
Secondary Perceived stress (PSS10) Assessed using the Perceived Stress Scale (PSS10) change in perceived stress in 3 months No
Secondary Pain coping strategies (CSQ24) assessed using the pain coping strategies questionnaire (CSQ24) change in pain coping strategies in 3 months No
Secondary Depressive symptoms (CESD-SF) assessed using the Short Form of Center for Epidemiological Studies scale (CESD-SF) change in depressive symptoms in 3 months No
Secondary Trust in physicians (Trust in Physicians Scale) assessed using the Trust in Physicians Scale change in trust in physicians in 3 months No
Secondary Medication Adherence (4-item Morisky Medication Adherence scale) assessed using the 4-item Morisky Medication Adherence scale change in medication adherence in 3 months No
Secondary Physical activity - usual daily activity participant self-report of usual daily activity (usually sit during the day, stand or walk but don't carry or lift things often, usually lift or carry light loads, or do heavy work or carry heavy loads) change in usual daily activity at 3 months No
Secondary Physical activity - number of days engaged in intense exercise in the past 7 days participant self report of number of days in the past week engaged in intense exercise (0-7 days) change in days of intense exercise at 3 months No
Secondary Physical activity - number of days walked for exercise in the past 7 days participant self report of number of days in the past week walked for exercise (0-7) change in days of walking for exercise at 3 months No
Secondary Physical activity - exercising when in pain questions participant self report of exercising when experiencing pain assessed by if the participant had no days unable to walk for exercise because of pain, unable to walk because of pain but did other exercises, or unable to walk because of pain but did not other forms of exercise. change exercising when in pain at 3 months No
Secondary Physical Activity - perception of physical activity compared to others participant self report of activity levels compared to others their age change in perception of physical activity at 3 months No
Secondary Diet - days eating high fat foods in the past 7 days participant self report of days in the past 7 days of eating high-fat foods change in the number of days of eating high fat foods at 3 months No
Secondary Diet - having a second serving at a meal in the past 7 days participant self report of days in the past 7 days of having a second serving at a meal in the past 7 days change in the number of days of having a second serving at a meal in the past 7 days No
Secondary Diet - eating unhealthy foods because of pain in the past 7 days participant self report of days in the past 7 days of eating unhealthy foods because of experiencing pain change in the number of days of eating unhealthy foods because of pain in the past 7 days at 3 months No
See also
  Status Clinical Trial Phase
Completed NCT03743779 - Mastering Diabetes Pilot Study
Completed NCT03786978 - Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus N/A
Completed NCT01804803 - DIgital Assisted MONitoring for DiabeteS - I N/A
Completed NCT05039970 - A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT04068272 - Safety of Bosentan in Type II Diabetic Patients Phase 1
Completed NCT03243383 - Readmission Prevention Pilot Trial in Diabetes Patients N/A
Completed NCT03730480 - User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS) N/A
Recruiting NCT02690467 - Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm. N/A
Completed NCT02229383 - Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus Phase 3
Completed NCT06181721 - Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes N/A
Completed NCT05799976 - Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure N/A
Recruiting NCT04489043 - Exercise, Prediabetes and Diabetes After Renal Transplantation. N/A
Withdrawn NCT03319784 - Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients Phase 4
Completed NCT03542084 - Endocrinology Auto-Triggered e-Consults N/A
Completed NCT02229396 - Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo Phase 3
Recruiting NCT05544266 - Rare and Atypical Diabetes Network
Completed NCT01892319 - An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
Completed NCT05031000 - Blood Glucose Monitoring Systems: Discounter Versus Brand N/A
Recruiting NCT04039763 - RT-CGM in Young Adults at Risk of DKA N/A